or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    CORT B 1.02 3.21
    ZTS B -0.49 2.88
    BMY B 2.24 2.88
    RPRX B 0.32 2.87
    CTLT B -0.56 2.86
    JAZZ F -2.13 2.86
    VTRS D -1.03 2.82
    PFE D -0.93 2.80
    LLY D -0.16 2.78
    JNJ C -0.04 2.76
    MRK F 1.04 2.76
    ITCI D -0.71 2.74
    AXSM C 0.71 2.70
    ELAN D -1.29 2.68
    OGN D -1.57 2.65
    PRGO F -2.94 2.61
    SAVA D -6.83 2.56
    EWTX B 2.32 2.22
    ARVN F 1.02 2.02
    PBH D -1.76 1.76
    AMPH C -0.37 1.76
    LBPH D 11.28 1.76
    TARS C -1.82 1.63
    COLL B 2.74 1.54
    SUPN D 2.63 1.50
    PCRX F 1.66 1.37
    LGND D 1.26 1.25
    ANIP D -0.30 1.25
    HRMY B -1.90 1.20
    OCUL C 4.14 1.04
    AMRX A 7.94 1.01
    HROW C -1.13 0.99
    FULC F 0.84 0.83
    INVA B 0.98 0.79
    PHAT C -6.08 0.78
    LQDA F 2.20 0.74
    MNMD F -1.05 0.71
    PLRX F -5.89 0.62
    EOLS B 5.06 0.59
    EYPT F 0.13 0.59
    ELVN B 1.80 0.51
    WVE C 1.22 0.51
    NUVB F 0.44 0.42
    XERS C -2.11 0.35

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Pharmaceutical Medicine Pharmaceutical Products Pain S&P 500 Alzheimer's Disease Animal Health Life Sciences Biotechnology Depression Diabetes Disease Drugs Hypertension Medication Neuroscience Pharmacology Suspension Acid
    Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Drug Manufacturers - General Medical Distribution

    Recent News for Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF & its Holdings

    Date Stock Title
    Oct 1 PLRX Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs
    Oct 1 LBPH Longboard Pharmaceuticals gains amid takeover speculation
    Oct 1 MRK U.S. port strike expected to have limited impact on healthcare supply chain: HHS
    Oct 1 LLY U.S. port strike expected to have limited impact on healthcare supply chain: HHS
    Oct 1 BMY PRME Stock Rises 11.8% on Collaboration With Bristol Myers
    Oct 1 LLY Here's how AI is set to disrupt healthcare — albeit slowly
    Oct 1 PFE The Covid Era Tech Promises To Reinvent Cancer Treatment
    Oct 1 BMY A schizophrenia win for BMS’ Cobenfy, but challenges lie ahead
    Oct 1 LLY t:slim X2's Compatibility With Lilly's Lyumjev Might Aid TNDM Stock
    Oct 1 PFE Lock In A Phenomenal Yield With Pfizer
    Oct 1 LLY Market Chatter: Eli Lilly Mulls Testing Weight-Loss Drugs on People With Normal Weight
    Oct 1 VTRS Is Viatris Inc. (VTRS) the Best Stock Under $15 To Buy Now?
    Oct 1 PFE ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
    Oct 1 LLY Lilly looking to test Zepbound as health maintenance drug: report
    Oct 1 PFE 3 Consistent Dividend Stocks for Passive Income: KO, PFE, MO
    Oct 1 LLY Roche Ramps Up Breast Cancer Pipeline With Regor's CDK Inhibitors
    Oct 1 JNJ Johnson & Johnson (NYSE:JNJ) is a favorite amongst institutional investors who own 73%
    Oct 1 CORT Wall Street Analysts Think Corcept (CORT) Could Surge 41.31%: Read This Before Placing a Bet
    Oct 1 JAZZ Is Jazz Pharmaceuticals (JAZZ) Stock Undervalued Right Now?
    Oct 1 CORT Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
    The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
    Exchange Traded Funds
    Back to the Main PILL Page...